Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond S Hansford, P Kaurah, H Li-Chang, M Woo, J Senz, H Pinheiro, ... JAMA oncology 1 (1), 23-32, 2015 | 766 | 2015 |
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia S Shah, KA Schrader, E Waanders, AE Timms, J Vijai, C Miething, ... Nature genetics 45 (10), 1226-1231, 2013 | 361 | 2013 |
Germline variants in targeted tumor sequencing using matched normal DNA KA Schrader, DT Cheng, V Joseph, M Prasad, M Walsh, A Zehir, A Ni, ... JAMA oncology 2 (1), 104-111, 2016 | 341 | 2016 |
Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome DL Worthley, KD Phillips, N Wayte, KA Schrader, S Healey, P Kaurah, ... Gut 61 (5), 774-779, 2012 | 308 | 2012 |
Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant J Li, SL Woods, S Healey, J Beesley, X Chen, JS Lee, H Sivakumaran, ... The American Journal of Human Genetics 98 (5), 830-842, 2016 | 241 | 2016 |
Homologous recombination deficiency and platinum-based therapy outcomes in advanced breast cancer EY Zhao, Y Shen, E Pleasance, K Kasaian, S Leelakumari, M Jones, ... Clinical Cancer Research 23 (24), 7521-7530, 2017 | 184 | 2017 |
Cancer genomics and inherited risk ZK Stadler, KA Schrader, J Vijai, ME Robson, K Offit Journal of clinical oncology 32 (7), 687-698, 2014 | 177 | 2014 |
Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia S Topka, J Vijai, MF Walsh, L Jacobs, A Maria, D Villano, P Gaddam, ... PLoS genetics 11 (6), e1005262, 2015 | 175 | 2015 |
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants K Lee, K Krempely, ME Roberts, MJ Anderson, F Carneiro, E Chao, ... Human mutation 39 (11), 1553-1568, 2018 | 166 | 2018 |
Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy KA Schrader, J Hurlburt, SE Kalloger, S Hansford, S Young, ... Obstetrics & Gynecology 120 (2 Part 1), 235-240, 2012 | 166 | 2012 |
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk TP Slavin, KN Maxwell, J Lilyquist, J Vijai, SL Neuhausen, SN Hart, ... NPJ breast cancer 3 (1), 22, 2017 | 157 | 2017 |
Hereditary diffuse gastric cancer: association with lobular breast cancer KA Schrader, S Masciari, N Boyd, S Wiyrick, P Kaurah, J Senz, W Burke, ... Familial cancer 7, 73-82, 2008 | 155 | 2008 |
A Recessive Founder Mutation in Regulator of Telomere Elongation Helicase 1, RTEL1, Underlies Severe Immunodeficiency and Features of Hoyeraal … BJ Ballew, V Joseph, S De, G Sarek, JB Vannier, T Stracker, KA Schrader, ... PLoS genetics 9 (8), e1003695, 2013 | 146 | 2013 |
Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes E Pleasance, E Titmuss, L Williamson, H Kwan, L Culibrk, EY Zhao, ... Nature Cancer 1 (4), 452-468, 2020 | 138 | 2020 |
Evaluation of ACMG-guideline-based variant classification of cancer susceptibility and non-cancer-associated genes in families affected by breast cancer KN Maxwell, SN Hart, J Vijai, KA Schrader, TP Slavin, T Thomas, ... The American Journal of Human Genetics 98 (5), 801-817, 2016 | 131 | 2016 |
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers J Laskin, S Jones, S Aparicio, S Chia, C Ch'ng, R Deyell, P Eirew, A Fok, ... Molecular Case Studies 1 (1), a000570, 2015 | 131 | 2015 |
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers KA Schrader, S Masciari, N Boyd, C Salamanca, J Senz, DN Saunders, ... Journal of medical genetics 48 (1), 64-68, 2011 | 112 | 2011 |
The specificity of the FOXL2 c. 402C> G somatic mutation: a survey of solid tumors KA Schrader, B Gorbatcheva, J Senz, A Heravi-Moussavi, N Melnyk, ... PloS one 4 (11), e7988, 2009 | 100 | 2009 |
Homologous recombination deficiency in breast cancer: a clinical review WD den Brok, KA Schrader, S Sun, AV Tinker, EY Zhao, S Aparicio, ... JCO Precision Oncology 1, 1-13, 2017 | 87 | 2017 |
Whole-genome and transcriptome analysis enhances precision cancer treatment options E Pleasance, A Bohm, LM Williamson, JMT Nelson, Y Shen, M Bonakdar, ... Annals of Oncology 33 (9), 939-949, 2022 | 82 | 2022 |